Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
3 studies found for:    HYPERKALEMIC PERIODIC PARALYSIS
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Completed
Has Results
Hyper- and Hypokalemic Periodic Paralysis Study
Conditions: Hyperkalemic Periodic Paralysis;   Hypokalemic Periodic Paralysis
Interventions: Drug: Dichlorphenamide (double-blind);   Drug: Placebo (double-blind);   Drug: Dichlorphenamide (open-label)
2 Recruiting Lamotrigine as Treatment of Myotonia
Conditions: Dystrophia Myotonica Type 1;   Myotonia Congenita;   Paramyotonia Congenita;   Hyperkalemic Periodic Paralysis;   Potassium-Aggravated Myotonia
Interventions: Drug: Lamotrigine;   Drug: Placebo
3 Completed Phase III Randomized, Double-Blind, Placebo-Controlled Study of Dichlorphenamide for Periodic Paralyses and Associated Sodium Channel Disorders
Conditions: Paralysis, Hyperkalemic Periodic;   Hypokalemic Periodic Paralysis;   Paramyotonia Congenita
Intervention: Drug: dichlorphenamide

Indicates status has not been verified in more than two years